IP Library Granted Patent US 7,056,682
Granted Patent B2
US 7,056,682 · App. 10/474,755 · Granted Jun 6, 2006

Immunoassay method and immunoassay reagent kit to be used therein

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,056,682
App. No.
10/474,755
Granted
Jun 6, 2006
Kind
B2
Abstract

In step St 1 shown in FIG. 1 , a reaction system including a sample for which the content of a subject substance is to be measured, a specific-binding substance specifically binding to the subject substance, and phthalic acid or phthalate salt is constructed. The pH of the reaction system is set at less than 7. When the subject substance is an antigen, the specific-binding substance is an antibody. In reverse, when the subject substance is an antibody, the specific-binding substance is an antigen. In step St 2 in FIG. 1 , an optical property of the reaction system is measured. When agglutinate complexes are produced in the step St 1 , the reaction system becomes turbid, causing a change in scattered light intensity, transmitted light amount and the like. Therefore, by measuring the scattered light intensity, the transmitted light amount or the like, the degree of turbidity of the reaction system can be estimated.

Claims (21)

1. An immunoreaction measurement method for measuring the content of a subject substance in a sample through optical measurement, comprising the steps of:

(A) constructing a reaction system including the sample containing said subject substance, a specific-binding substance specifically binding to the subject substance and phthalic acid or phthalate salt; and

(B) measuring an optical property of the reaction system,

wherein in the step (A), the pH of the reaction system is set in a range of 4.5 to 5.5

and the subject substance and the specific-binding substance is a combination of an antigen and an antibody, and

in the step (B), a degree of turbidity of the reaction system is measured.

2. The immunoreaction measurement method of claim 1 , wherein the optical property is a scattered light intensity or a transmitted light amount.

3. The immunoreaction measurement method of claim 1 , wherein in the step (A), the reaction system further includes a buffering agent.

4. The immunoreaction measurement method of claim 1 , wherein in the step (A), the concentration of the phthalic acid or phthalate salt in the reaction system is 0.2 M or less.

5. The immunoreaction measurement method of claim 1 , wherein the phthalate salt is potassium hydrogen phthalate.

6. The immunoreaction measurement method of claim 1 , wherein the reaction system includes 2 to 6 wt. % polyethylene glycol.

7. The immunoreaction measurement method of claim 1 , wherein the subject substance is an antigen having a structure which can hold metal ions inside, and

the specific-binding substance is an antibody specifically binding to the antigen in a state that the metal ions have been released therefrom.

8. The immunoreaction measurement method of claim 7 , wherein the subject substance is human C-reactive protein.

9. The immunoreaction measurement method of claim 1 , wherein the subject substance is an antigen having a structure of holding metal ions inside,

the specific-binding substance is a polyclonal antibody, and

in the step (A), the reaction system further includes the metal ions.

10. The immunoreaction measurement method of claim 9 , wherein the subject substance is human C-reactive protein.

11. The immunoreaction measurement method of claim 1 , wherein the subject substance is an antigen, and

the specific-binding substance is a monoclonal antibody capable of binding to a plurality of binding sites of the antigen.

12. The immunoreaction measurement method of claim 11 , wherein the subject substance is human C-reactive protein.

Assignments (7)
CHANGE OF NAME Recorded Jun 29, 2018
From: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
To: PHC HOLDINGS CORPORATION
Reel/Frame 046459/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2014
From: PANASONIC CORPORATION
To: PHC HOLDINGS CO., LTD.
Reel/Frame 032785/0498 →
CHANGE OF NAME Recorded Apr 29, 2014
From: PHC HOLDINGS CO., LTD.
To: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
Reel/Frame 032785/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2014
From: PANASONIC HEALTHCARE CO., LTD.
To: PANASONIC CORPORATION
Reel/Frame 032480/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2014
From: PANASONIC CORPORATION
To: PANASONIC HEALTHCARE CO., LTD.
Reel/Frame 032360/0795 →
CHANGE OF NAME Recorded Feb 25, 2014
From: MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
To: PANASONIC CORPORATION
Reel/Frame 032332/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2003
From: KAMEI, AKIHITO; KENJO, NORIKO; KAWAMURA, TATSURO; HIRAI, MAHITO
To: MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
Reel/Frame 015006/0838 →